Pharmaceutical
Spikevax (previously COVID-19 Vaccine Moderna)-H-C-5791-R-0025: EPAR - Assessment report - Renewal
Advanced pharmaceutical formulation for targeted therapeutic intervention.
Advanced pharmaceutical formulation for targeted therapeutic intervention.